BRIEF published on 02/03/2026 at 12:17, 7 months 19 days ago GeNeuro SA bankrupt after the end of the composition moratorium Biopharmaceutical Bankruptcy GeNeuro Geneva Court Concordat Moratorium
BRIEF published on 02/03/2026 at 12:14, 7 months 19 days ago GeNeuro SA Declares Bankruptcy Following Debt Moratorium Biopharmaceutical Bankruptcy Court Ruling GeNeuro SA Debt Moratorium
PRESS RELEASE published on 02/03/2026 at 12:09, 7 months 19 days ago INSIDE INFORMATION / OTHER NEWS RELEASES GeNeuro SA announces the end of debt moratorium and commencement of bankruptcy proceedings after Geneva Court ruling. Further details in official publications Biopharmaceutical Company GeNeuro SA Bankruptcy Proceedings Debt Moratorium Geneva Court Ruling
BRIEF published on 01/23/2026 at 11:05, 7 months 30 days ago GeNeuro SA Suspends Trading Ahead of Court Ruling Euronext Paris Trading Suspension GeNeuro Debt Moratorium Geneva Court
BRIEF published on 01/23/2026 at 11:05, 7 months 30 days ago Temporary suspension of trading of GeNeuro SA shares on Euronext Paris Restructuring GeNeuro SA Geneva Court Trading Suspended Concordat Moratorium
PRESS RELEASE published on 01/23/2026 at 11:00, 7 months 30 days ago Inside Information / Other news releases GeNeuro SA requests temporary suspension of trading on Euronext Paris pending Geneva Court judgment on debt moratorium. Details on debt restructuring and impact on operations Euronext Paris GeNeuro SA Swiss Law Temporary Suspension Debt Moratorium
BRIEF published on 10/15/2025 at 20:30, 11 months 6 days ago GeNeuro Delays Half-Year Financial Report Release Financial Report Restructuring Biopharmaceutical GeNeuro Debt Moratorium
PRESS RELEASE published on 10/15/2025 at 20:25, 11 months 6 days ago Inside Information / Other news releases GeNeuro SA postpones the publication of June 30, 2025 half-yearly financial report to assess financial impacts of debt-restructuring moratorium extension. New date to be announced Financial Report Postponement Neurological Disorders GeNeuro SA Debt-restructuring Moratorium
BRIEF published on 09/26/2025 at 18:41, 11 months 26 days ago GeNeuro SA: Extension of the debt restructuring stay until 2026 Restructuring GeNeuro Neurological Diseases Composition Stay Geneva Court
PRESS RELEASE published on 09/26/2025 at 18:36, 11 months 26 days ago Inside Information / Other news releases GeNeuro SA extends its definitive debt-restructuring moratorium until January 27, 2026, to explore strategic options and continue developing treatments for neurodegenerative and autoimmune diseases Autoimmune Diseases GeNeuro SA Neurodegenerative Diseases Debt-restructuring Moratorium
Published on 09/22/2026 at 17:00, 2 hours 55 minutes ago Leggett Dynamics Expands Asia Pacific Headquarters
Published on 09/22/2026 at 16:30, 3 hours 25 minutes ago Formation Metals Intersects 0.98 g/t Au over 95.6 Metres Starting 7 Metres Below Surface, Including 3.14 g/t Au over the First 10 Metres, Extending the A-Zone Up to 50 Metres North at N2
Published on 09/22/2026 at 15:25, 4 hours 30 minutes ago Aztec Minerals Announces Closing of Upsized C$6.4 Million Bought Deal Private Placement Including Concurrent Exercise of Underwriter's Option
Published on 09/22/2026 at 15:20, 4 hours 35 minutes ago MicroVision Introduces Advanced Photonics Technology for Next-Generation AI Data Center Scale-Up Architecture
Published on 09/22/2026 at 19:40, 14 minutes ago EQS-Adhoc: Pyrum Innovations AG: Revision of the Forecast for the Financial Year 2026
Published on 09/22/2026 at 19:00, 55 minutes ago LLB focuses on its "elevate" strategy for growth, excellence and resilience
Published on 09/22/2026 at 18:30, 1 hour 25 minutes ago Avolta partners with Hawaii’s Department of Transportation to expand airport dining at three airports
Published on 09/22/2026 at 17:45, 2 hours 10 minutes ago Carvolix submits 510(k) for TAVIPILOT Robot, advancing toward US commercial launch of Its Integrated TAVIPILOT Platform.
Published on 09/22/2026 at 17:40, 2 hours 15 minutes ago VALBIOTIS SA: Valbiotis announces positive results from the Cardio-Liver clinical study - Commercial launch of ValbiotisPRO® Foie on September 23
Published on 09/22/2026 at 18:00, 1 hour 55 minutes ago Consolidated results for the first half of 2026 EBITDA : 60,5 M€
Published on 09/22/2026 at 17:45, 2 hours 10 minutes ago Imerys-09-2026-information-share-capital-and-voting-rights-as-of-31-August-2026
Published on 09/21/2026 at 18:19, 1 day 1 hour ago Reporting on share buyback transactions carried out between September 14 and September 18, 2026
Published on 09/21/2026 at 18:01, 1 day 1 hour ago Partnership agreement signed between Manitou Group and HD Construction Equipment
